良性卵巢囊肿术中溢出短期与长期并发症:系统综述与Meta分析
该系统综述与Meta分析纳入28项定性研究、12项定量研究,评估良性卵巢囊肿术中破裂溢出的短期与长期并发症。结果显示溢出与再手术、不孕、发热、再入院无显著关联,但与良性复发风险升高相关;仅畸胎瘤亚组中溢出与术后化学性腹膜炎相关。
要点
- 良性卵巢囊肿术中溢出与再手术、不孕、发热、再入院无显著关联。
- 术中溢出与良性复发风险升高相关(RR 3.1;95%CI 1.05-9.14)。
- 畸胎瘤亚组中溢出与术后化学性腹膜炎相关(RR 9.36;95%CI 1.20-73.28)。
核心结论
- 良性卵巢囊肿术中溢出与有限的临床不良结局相关。
- 手术方式(微创或开腹)不应因担心中术中囊肿破裂而改变,但应尽最大努力防止腹腔内溢出。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南。
- 检索Cochrane Central Register of Controlled Trials、BIOSIS、Medline(Ovid)、Web of Science、ClinicalTrials.gov和Google Scholar。
- 纳入比较术中溢出与无溢出的卵巢囊肿手术结局的随机对照研究和观察性研究。
- 共28项研究纳入定性分析,12项纳入定量分析。
主要发现
- 卵巢囊肿直径与溢出风险无关(RR 0.75;95%CI -0.33至1.82)。
- 术中良性卵巢囊肿破裂与再手术无关(RR 1.16;95%CI 0.39-3.48)。
- 术中溢出与不孕无关(RR 0.73;95%CI 0.15-3.63)。
- 术中溢出与短暂发热无关(RR 3.22;95%CI 0.83-12.51)。
- 术中溢出与再入院无关(RR 1.00;95%CI 0.33-2.98)。
关键数值与推荐
- 术中溢出与良性复发风险升高相关(RR 3.1;95%CI 1.05-9.14)。
- 仅纳入畸胎瘤的研究亚组分析显示,术中囊肿破裂与术后化学性腹膜炎相关(RR 9.36;95%CI 1.20-73.28)。
临床怎么用
- 良性卵巢囊肿手术中应尽最大努力防止腹腔内溢出。
- 不应因担心中术中囊肿破裂而改变微创或开腹的手术方式选择。
- 对畸胎瘤患者需特别关注术中溢出与术后化学性腹膜炎的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To review short- and long-term complications associated with intraoperative rupture of benign ovarian cysts. DATA SOURCES: The Cochrane Central Register of Controlled Trials, BIOSIS, Medline (Ovid), Web of Science, ClinicalTrials.gov, and Google Scholar were searched using the following terms and their combinations: "spillage," "rupture," "leakage," "ovarian cyst," "teratoma," "dermoid," "operative," "surgery," "outcome." METHODS OF STUDY SELECTION: Randomized controlled and observational studies evaluating the operative outcomes of surgical treatment of ovarian cysts with intraoperative spillage compared with those of surgical treatment of ovarian cysts without spillage were included. A systematic review and meta-analysis following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines was performed. TABULATION, INTEGRATION, AND RESULTS: A total of 28 studies were included in the qualitative analysis and 12 in the quantitative analysis. Ovarian cyst diameter was not found to be associated with the risk for spillage (relative risk [RR] 0.75; 95% confidence interval [CI], -0.33 to 1.82). Intraoperative benign ovarian cyst rupture was not associated with adverse short- and long-term outcomes such as reoperation (RR 1.16; 95% CI, 0.39-3.48), infertility (RR 0.73; 95% CI, 0.15-3.63), transient fever (RR 3.22; 95% CI, 0.83-12.51), and readmission (RR 1.00; 95% CI, 0.33-2.98). However, intraoperative spillage was found to be associated with increased risk for benign recurrence (RR 3.1; 95% CI, 1.05-9.14). A subgroup analysis of the studies that included only dermoid cysts showed an association between intraoperative cyst rupture and postoperative chemical peritonitis (RR 9.36; 95% CI, 1.20-73.28). CONCLUSION: Intraoperative ovarian cyst spillage of a benign cyst is associated with limited adverse clinical outcomes. Although the surgical approach (minimally invasive vs open) should not be affected by the concern regarding an intraoperative cyst rupture, maximal efforts should be made to prevent intra-abdominal spillage.
引用
- Eisenberg N, Volodarsky-Perel A, Brochu I, et al. Short- and Long-Term Complications of Intraoperative Benign Ovarian Cyst Spillage: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2020. PMID: 33279627. doi:10.1016/j.jmig.2020.11.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。